Oruka (ORKA) General Counsel Paul T. Quinlan Sells 1,039 Shares

What Happened

• Paul T. Quinlan, General Counsel of Oruka Therapeutics (ORKA), sold 1,039 shares on 2026-09-15 at $95.71 per share for proceeds of $99,443. The transaction was an open-market/private sale executed as a sell-to-cover related to the vesting of restricted stock units (RSUs).

Key Details

• Transaction date: 2026-09-15
• Transaction type/code: Sale (S) — open market or private sale
• Price per share: $95.71
• Total proceeds: $99,443
• Reason/footnote: Sale effected under the company’s automatic, non-discretionary sell-to-cover procedure to satisfy tax withholding on RSU vesting (Footnote F1)
• Shares owned after transaction: Not reported in the provided filing
• Filing timeliness: No late filing indicated in the provided record

Context

• This sale was a routine sell-to-cover to satisfy tax withholding obligations arising from RSU vesting, which is common and typically does not by itself indicate the insider’s view on the company’s prospects. No 10b5-1 plan or other trading plan was indicated in the filing.